DGKB抗体,Rabbit Polyclonal DGKB Antibody
  • DGKB抗体,Rabbit Polyclonal DGKB Antibody
  • DGKB抗体,Rabbit Polyclonal DGKB Antibody
  • DGKB抗体,Rabbit Polyclonal DGKB Antibody

DGKB抗体;DGKB Antibody—艾普蒂

价格 询价
包装 20μl 50μl 100μl
最小起订量 1μl
发货地 上海
更新日期 2025-05-26
QQ交谈 微信洽谈

产品详情

中文名称:DGKB抗体英文名称:Rabbit Polyclonal DGKB Antibody
品牌: 艾普蒂产地: 武汉
保存条件: Stored at -20°C for 6110 year. Avoid repeated freeze / thaw cycles.产品类别: 抗体
重组: 应用: WB: IHC-P: IHC-F: ICC/IF: IP:FC:ChIP: ELISA
种属反应性: Human,Mouse,Rat 宿主: Rabbit
偶联物: 靶点: DGKB
2025-05-26 DGKB抗体 Rabbit Polyclonal DGKB Antibody 20μl/RMB;50μl/RMB;100μl/RMB 艾普蒂 武汉 Stored at -20°C for 6110 year. Avoid repeated freeze / thaw cycles. 抗体

验证与应用

应用及物种
WB咨询技术 Human,Mouse,Rat
IF咨询技术 Human,Mouse,Rat
IHC1/50-1/200 Human,Mouse,Rat
ICC技术咨询 Human,Mouse,Rat
FCM咨询技术 Human,Mouse,Rat
Elisa1/1000-1/5000 Human,Mouse,Rat
   

产品详情

AliasesDGK; DAGK2; DGK-BETA
Host/IsotypeRabbit IgG
Antibody TypePrimary antibody
StorageStore at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze/thaw cycles.
Species ReactivityHuman, Mouse, Rat
ImmunogenSynthetic peptide of human DGKB
FormulationPurified antibody in PBS with 0.05% sodium azide and 50% glycerol.

+ +

  •  

     

       The image is immunohistochemistry of paraffin-embedded Human liver cancer tissue using P11522(DGKB Antibody) at dilution 1/60. (Original magnification: ×200)    


  •  

     

       The image is immunohistochemistry of paraffin-embedded Human breast cancer tissue using P11522(DGKB Antibody) at dilution 1/60. (Original magnification: ×200)    


           

参考文献

以下是关于DGKB抗体的参考文献示例(注:以下为模拟内容,实际文献需通过学术数据库查询):

1. **文献名称**:*"Diacylglycerol kinase β regulates lipid metabolism and progression in renal cell carcinoma"*

**作者**:Yamamoto K, et al.

**摘要**:通过DGKB特异性抗体分析肾癌细胞系及组织样本,发现DGKB通过调节脂质信号通路促进肿瘤生长,其表达水平与患者生存率显著相关。

2. **文献名称**:*"DGKB-dependent signaling pathways in hippocampal neuronal development"*

**作者**:Chen L, et al.

**摘要**:利用DGKB抗体进行免疫染色和Western blot,证实DGKB在小鼠海马神经元突触可塑性中起关键作用,敲除后导致认知功能缺陷。

3. **文献名称**:*"Altered DGKB expression in type 2 diabetes: Insights from adipose tissue analysis"*

**作者**:Martinez R, et al.

**摘要**:研究通过DGKB抗体检测2型糖尿病患者的脂肪组织,发现DGKB表达下调与胰岛素抵抗相关,提示其在脂质代谢紊乱中的病理作用。

4. **文献名称**:*"Development and validation of a high-specificity DGKB monoclonal antibody for autoimmune disease studies"*

**作者**:Sato T, et al.

**摘要**:报道一种新型DGKB单克隆抗体的制备与验证,应用于类风湿性关节炎模型,证明DGKB通过调节T细胞活性参与炎症反应。

建议通过**PubMed/Google Scholar**以“DGKB antibody”或“diacylglycerol kinase beta”为关键词检索最新文献。

       

背景信息

The DGKB antibody targets diacylglycerol kinase beta (DGKB), an enzyme encoded by the *DGKB* gene, which belongs to the diacylglycerol kinase (DGK) family. DGKB catalyzes the conversion of diacylglycerol (DAG) to phosphatidic acid (PA), a critical step in regulating lipid-mediated signaling pathways. By modulating DAG and PA levels, DGKB influences cellular processes such as membrane trafficking, cell proliferation, and apoptosis. It is particularly abundant in the brain, where it plays a role in neuronal development, synaptic plasticity, and neurotransmitter release, though it is also expressed in immune cells, adipose tissue, and other organs.

DGKB dysfunction has been implicated in metabolic disorders, immune dysregulation, and neurological conditions. Studies link altered DGKB activity to insulin resistance, obesity, and bipolar disorder, highlighting its therapeutic potential. The DGKB antibody is a key tool for investigating these roles, enabling detection and quantification of DGKB protein in tissues or cells via techniques like Western blot, immunohistochemistry, or flow cytometry. Researchers use it to explore DGKB's expression patterns, post-translational modifications, and interactions with signaling molecules. Validated antibodies are essential for specificity, often confirmed through knockout controls or blocking peptides. As interest grows in lipid signaling and metabolic diseases, the DGKB antibody remains vital for elucidating DGKB's physiological and pathological mechanisms.

       
关键字: DGKB抗体;DGKB;DGKB Antibody;

公司简介

生物技术有限公司
成立日期 2024-07-02 (2年) 注册资本 20万人民币
员工人数 1-10人 年营业额 ¥ 100万以内
主营行业 抗体,植物生物技术,细胞培养,蛋白组学 经营模式 贸易,工厂,试剂,定制,服务
  • 上海切尔齐生物科技有限公司
VIP 1年
  • 公司成立:2年
  • 注册资本:20万人民币
  • 企业类型:有限责任公司(自然人投资或控股)
  • 主营产品:生物试剂
  • 公司地址:青浦
询盘

DGKB抗体;DGKB Antibody—艾普蒂相关厂家报价

产品名称 价格   公司名称 报价日期
询价
VIP4年
维百奥(北京)生物科技有限公司
2025-12-29
询价
上海华盈生物医药科技有限公司
2025-12-28
¥1338
VIP2年
普健生物(武汉)科技有限公司
2026-01-05
¥1280
湖北艾普蒂生物工程有限公司
2025-06-04
内容声明:
以上所展示的信息由商家自行提供,内容的真实性、准确性和合法性由发布商家负责。 商家发布价格指该商品的参考价格,并非原价,该价格可能随着市场变化,或是由于您购买数量不同或所选规格不同而发生变化。最终成交价格,请咨询商家,以实际成交价格为准。请意识到互联网交易中的风险是客观存在的
主页 | 企业会员服务 | 广告业务 | 联系我们 | 旧版入口 | 中文MSDS | CAS Index | 常用化学品CAS列表 | 化工产品目录 | 新产品列表 |投诉中心
Copyright © 2008 ChemicalBook 京ICP备07040585号  京公海网安备110108000080号  All rights reserved.